Fulgent Genetics (FLGT) News Today → Bill Gates is all about this tiny $2 stock (From Timothy Sykes) (Ad) Free FLGT Stock Alerts $22.11 -0.39 (-1.73%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | businesswire.comMoffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer TherapeuticsMay 6, 2024 | finance.yahoo.comFulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagMay 6, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Stock Price Up 5.5%Fulgent Genetics (NASDAQ:FLGT) Trading 5.5% HigherMay 4, 2024 | finance.yahoo.comFulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call TranscriptMay 4, 2024 | finance.yahoo.comFulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...May 4, 2024 | finance.yahoo.comQ1 2024 Fulgent Genetics Inc Earnings CallMay 3, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Releases FY 2024 Earnings GuidanceFulgent Genetics (NASDAQ:FLGT) updated its FY 2024 earnings guidance. The company provided EPS guidance of -1.050--1.050 for the period, compared to the consensus estimate of -1.060. The company also issued revenue guidance of $280.0 millionillion-$280.0 millionillion, compared to the consensus estimate of $279.4 millionillion.May 3, 2024 | investorplace.comFLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024May 3, 2024 | msn.comOptions Volatility and Implied Earnings Moves Today, May 03, 2024May 3, 2024 | msn.comFulgent Genetics reports mixed Q1 results; reaffirms FY24 outlookMay 3, 2024 | finance.yahoo.comFulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider LossesMay 3, 2024 | businesswire.comFulgent Reports First Quarter 2024 Financial ResultsMay 2, 2024 | markets.businessinsider.comFulgent Genetics is about to announce earnings — here's what Wall Street expectsApril 23, 2024 | marketbeat.comMirae Asset Global Investments Co. Ltd. Trims Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)Mirae Asset Global Investments Co. Ltd. lowered its position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 57.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 43,794 shares of the company's stock after selling 59,588 shares duApril 17, 2024 | morningstar.comFulgent Genetics Inc FLGTApril 17, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Reaches New 12-Month Low at $20.32Fulgent Genetics (NASDAQ:FLGT) Hits New 52-Week Low at $20.32April 11, 2024 | businesswire.comFulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024April 11, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Sets New 52-Week Low at $20.66Fulgent Genetics (NASDAQ:FLGT) Reaches New 52-Week Low at $20.66April 11, 2024 | finance.yahoo.comFulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five yearsApril 1, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Reaches New 1-Year Low at $21.20Fulgent Genetics (NASDAQ:FLGT) Sets New 52-Week Low at $21.20March 31, 2024 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Up 22.6% in MarchFulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 611,200 shares, an increase of 22.6% from the February 29th total of 498,400 shares. Approximately 3.2% of the company's shares are short sold. Based on an average daily trading volume, of 208,900 shares, the short-interest ratio is currently 2.9 days.March 22, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Hits New 1-Year Low at $21.26Fulgent Genetics (NASDAQ:FLGT) Reaches New 1-Year Low at $21.26March 16, 2024 | finance.yahoo.comFLGT Apr 2024 20.000 callMarch 14, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Sets New 1-Year Low at $22.25Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low at $22.25March 9, 2024 | marketbeat.comInvesco Ltd. Has $8.36 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)Invesco Ltd. raised its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 150.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 312,627 shares of the company's stock after acquiring an addMarch 6, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) PT Lowered to $25.00 at Piper SandlerPiper Sandler lowered their target price on shares of Fulgent Genetics from $28.00 to $25.00 and set a "neutral" rating for the company in a report on Wednesday.March 1, 2024 | seekingalpha.comFulgent Genetics (FLGT) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finance.yahoo.comFulgent Genetics Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 1, 2024 | finance.yahoo.comAn Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% UndervaluedFebruary 29, 2024 | insidermonkey.comFulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | finance.yahoo.comQ4 2023 Fulgent Genetics Inc Earnings CallFebruary 28, 2024 | markets.businessinsider.comHere's what to expect from Fulgent Genetics's earnings reportFebruary 28, 2024 | finance.yahoo.comFulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023February 28, 2024 | marketbeat.comFulgent Genetics (NASDAQ:FLGT) Updates FY 2024 Earnings GuidanceFulgent Genetics (NASDAQ:FLGT) updated its FY 2024 earnings guidance. The company provided EPS guidance of -1.050--1.050 for the period, compared to the consensus estimate of -0.950. The company also issued revenue guidance of $280.0 millionillion-$280.0 millionillion, compared to the consensus estimate of $294.2 millionillion.February 28, 2024 | businesswire.comFulgent Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 25, 2024 | marketbeat.comBrandywine Global Investment Management LLC Invests $2.43 Million in Fulgent Genetics, Inc. (NASDAQ:FLGT)Brandywine Global Investment Management LLC acquired a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 90,867 shares of the companyFebruary 21, 2024 | seekingalpha.comFulgent Genetics: Buy Growth Ahead Below Liquidation ValueFebruary 17, 2024 | finance.yahoo.comFLGT Mar 2024 30.000 callFebruary 17, 2024 | finance.yahoo.comFLGT Mar 2024 35.000 putFebruary 13, 2024 | finance.yahoo.comFulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024February 12, 2024 | msn.comCooperSurgical and Fulgent partner on newborn genetic screening panelsFebruary 9, 2024 | marketbeat.comCampbell & CO Investment Adviser LLC Acquires 42,495 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)Campbell & CO Investment Adviser LLC raised its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 461.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,700 shareJanuary 17, 2024 | marketbeat.comFulgent Genetics, Inc. (NASDAQ:FLGT) Sees Significant Decrease in Short InterestFulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) saw a significant decrease in short interest in December. As of December 31st, there was short interest totalling 551,900 shares, a decrease of 15.0% from the December 15th total of 649,400 shares. Currently, 2.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 217,600 shares, the short-interest ratio is currently 2.5 days.January 3, 2024 | marketbeat.comTrellus Management Company LLC Makes New $1.15 Million Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)Trellus Management Company LLC bought a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 43,100 shares of the company's stock, vJanuary 3, 2024 | marketbeat.comTrellus Management Company LLC Makes New $1.15 Million Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT)Trellus Management Company LLC bought a new position in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 43,100 shares of the company's stock, vDecember 3, 2023 | finance.yahoo.comThe 3 Best Digital Health Stocks for Personalized MedicineDecember 1, 2023 | seekingalpha.comFollowing Up On Fulgent GeneticsNovember 14, 2023 | businesswire.comFulgent to Participate in the Piper Sandler 35 th Annual Healthcare ConferenceNovember 14, 2023 | finance.yahoo.comFulgent to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNovember 5, 2023 | finance.yahoo.comFulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it. Click on Adam's shiny forehead for more details. FLGT Media Mentions By Week FLGT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FLGT News Sentiment▼-0.120.42▲Average Medical News Sentiment FLGT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FLGT Articles This Week▼11▲FLGT Articles Average Week Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CSTL News Today CDNA News Today CELC News Today VRDN News Today SERA News Today BDSX News Today GTH News Today BNR News Today PSNL News Today RNLX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FLGT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.